Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pedram Asadi Sarabi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Therapeutic Targets|December 11, 2023
XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinomaZahra Hendi, Pedram Asadi Sarabi, David Hay, et al.
Human Immunology|December 6, 2024
Developing a multi-epitope vaccine against Helicobacter PyloriPedram Asadi Sarabi, Elham Rismani, Mahshid Shabanpouremam, et al.
European Journal of Pharmacology|October 25, 2024
AI-Based solutions for current challenges in regenerative medicinePedram Asadi Sarabi, Mahshid Shabanpouremam, Amir Reza Eghtedari, et al.
International Journal of Genomics|February 27, 2026
Extracellular Matrix-Associated Biomarkers for Hepatocellular Carcinoma: Insights From Machine Learning and Single-Cell AnalysisPedram Asadi Sarabi, Elham Rismani, Amir Ali Judaki, et al.
Pathology, Research and Practice|October 8, 2024
Exploring circulating MiRNA signature for osteosarcoma detection: Bioinformatics-based analyzing and validationNegar Heidari, Massoud Vosough, Abolfazl Bagherifard, et al.
Regenerative Therapy|July 21, 2025
Current challenges and future directions of ATMPs in regenerative medicineFatemeh Abbasi Kakroodi, Elaheh Khodadoust, Marzieh Alizadeh, et al.
International Immunopharmacology|June 28, 2025
Hypoimmunogenic pluripotent stem cells: A game-changer in cell-based regenerative medicinePedram Asadi-Sarabi, Elham Rismani, Mahshid Shabanpouremam, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Therapeutic Targets|December 11, 2023
XBP1 as a novel molecular target to attenuate drug resistance in hepatocellular carcinomaZahra Hendi, Pedram Asadi Sarabi, David Hay, et al.
Human Immunology|December 6, 2024
Developing a multi-epitope vaccine against Helicobacter PyloriPedram Asadi Sarabi, Elham Rismani, Mahshid Shabanpouremam, et al.
European Journal of Pharmacology|October 25, 2024
AI-Based solutions for current challenges in regenerative medicinePedram Asadi Sarabi, Mahshid Shabanpouremam, Amir Reza Eghtedari, et al.
International Journal of Genomics|February 27, 2026
Extracellular Matrix-Associated Biomarkers for Hepatocellular Carcinoma: Insights From Machine Learning and Single-Cell AnalysisPedram Asadi Sarabi, Elham Rismani, Amir Ali Judaki, et al.
Pathology, Research and Practice|October 8, 2024
Exploring circulating MiRNA signature for osteosarcoma detection: Bioinformatics-based analyzing and validationNegar Heidari, Massoud Vosough, Abolfazl Bagherifard, et al.
Regenerative Therapy|July 21, 2025
Current challenges and future directions of ATMPs in regenerative medicineFatemeh Abbasi Kakroodi, Elaheh Khodadoust, Marzieh Alizadeh, et al.
International Immunopharmacology|June 28, 2025
Hypoimmunogenic pluripotent stem cells: A game-changer in cell-based regenerative medicinePedram Asadi-Sarabi, Elham Rismani, Mahshid Shabanpouremam, et al.
Pageof 1